Elicera Therapeutics AB Asset Resilience Ratio

Latest as of December 2022: 0.00%

Elicera Therapeutics AB asset resilience ratio. Elicera Therapeutics AB (ELIC) has an Asset Resilience Ratio of 0.00% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Elicera Therapeutics AB defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Skr17.00

≈ $1.83 USD Cash + Short-term Investments

Total Assets

Skr46.31 Million

≈ $4.98 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Elicera Therapeutics AB (2022–2022)

Asset resilience ratio of Elicera Therapeutics AB from 2022 to 2022. This chart shows how Elicera Therapeutics AB's Asset Resilience Ratio has changed over time. Read Elicera Therapeutics AB total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Elicera Therapeutics AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ELIC total asset value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr17.00	0.0%
Total Liquid Assets	Skr17.00	0.00%

Asset Resilience Insights

Limited Liquidity: Elicera Therapeutics AB maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Elicera Therapeutics AB Industry Peers by Asset Resilience Ratio

Compare Elicera Therapeutics AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Elicera Therapeutics AB Asset Resilience Ratio by Year (2022–2022)

Elicera Therapeutics AB asset resilience ratio by year from 2022 to 2022. The table below shows the annual Asset Resilience Ratio data for Elicera Therapeutics AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	0.00%	Skr17.00 ≈ $1.83	Skr46.31 Million ≈ $4.98 Million	--

pp = percentage points

About Elicera Therapeutics AB

ST:ELIC Sweden Biotechnology

Market Cap

$13.66 Million

Skr126.92 Million SEK

Market Cap Rank

#26103 Global

#532 in Sweden

Share Price

Skr2.62

Change (1 day)

-2.06%

52-Week Range

Skr2.30 - Skr6.80

All Time High

Skr8.56